Listed

Champions Oncology, Inc.: Form 10-K for the period ended Apr 30, 2016

Filed with the SEC on Jul 29, 2016 and accepted by EDGAR at Jul 29, 2016, 13:09 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-04-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development12 months2015-05-01 to 2016-04-30$4.2mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2015-05-01 to 2016-04-30−$10.3mus-gaap:OperatingIncomeLoss
Income tax12 months2015-05-01 to 2016-04-30$92.0kus-gaap:IncomeTaxExpenseBenefit
Net income12 months2015-05-01 to 2016-04-30−$10.4mus-gaap:NetIncomeLoss
Diluted EPS12 months2015-05-01 to 2016-04-30−$1.20us-gaap:EarningsPerShareDiluted
Basic EPS12 months2015-05-01 to 2016-04-30−$1.20us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2015-05-01 to 2016-04-308,695,199 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2015-05-01 to 2016-04-30−$6.5mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2015-05-01 to 2016-04-30$322.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2016-04-30$2.6mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-04-30$4.3mus-gaap:AssetsCurrent
Total assetsAt period end2016-04-30$5.8mus-gaap:Assets
Current liabilitiesAt period end2016-04-30$5.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-04-30$5.5mus-gaap:Liabilities
Shareholders' equityAt period end2016-04-30$238.0kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001628280-16-017936. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.